3.
厄洛替尼治疗114例复发性非小细胞肺癌患者血清肿瘤标志物与PFS的多因素分析
Multivariate analysis of PFS and serum tumor markers in the 114 recurrent lung cancer patients treated with Erlotinib
| PFS | ||
| HR(95%CI) | P | |
| PFS: progression-free survival. | ||
| SP-D | 1.865 (1.14-3.04) | 0.013 |
| TGF-α | 0.929 (0.56-1.55) | 0.780 |
| MMP-9 | 1.357 (0.85-2.18) | 0.206 |
| KL-6 | 1.253 (0.77-2.03) | 0.359 |
| TPS | 1.698 (1.03-2.79) | 0.037 |